I hope so. But, frankly, most national and local responses to this outbreak have been subpar. I do not take it for granted that we (the US) can pull off this major logistical challenge smoothly or on an aggressive timeline.
New vaccines will likely be approved over the next few weeks (particularly the Oxford one), greatly increasing supply, and the kinks around distribution and administration will be slowly worked out (the Oxford one will also reduce the logistical challenges there; no special transport or storage needed). I'd be very surprised if rates don't go up considerably within a month.
Is that likely to get approved in the US? My understanding is that the trial was not good enough to pass the FDA bar.
Ah, looks like they may hold off til Feb. for US approval. (Results expected from another trial by then)